Zhen Zhang, MD
Fudan University · Zhujiang Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Zhen Zhang, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:44 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07877597 · Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally Advanced Colon Cancer With pMMR/MSSFudan University · not yet recruiting · Locally Advanced Colon Cancer, pMMR · principal investigator
- Ph2NCT07183865 · Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)Fudan University · recruiting · Locally Recurrent Rectal Cancer · principal investigator
- Ph2NCT06928584 · Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal CancerFudan University · recruiting · Locally Recurrent Rectal Cancer · principal investigator
- Ph2NCT06281405 · CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal CancerFudan University · recruiting · Locally Advanced Rectal Cancer, Neoadjuvant Therapy · principal investigator
- Ph2NCT05963490 · Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal CancerFudan University · unknown · Microsatellite Stable Metastatic Colorectal Cancer · principal investigator
- Ph2NCT05628038 · The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal CancerFudan University · unknown · Recurrent Rectal Cancer · principal investigator
- Ph3NCT04997837 · Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ AdenocarcinomaFudan University · recruiting · Gastric Cancer · principal investigator
- Ph2NCT04948034 · The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)Fudan University · unknown · Metastatic Colorectal Cancer · principal investigator
- N/ANCT04886778 · Efficacy and Safety of Low-Carbohydrate Diet Combined With Probiotics for Weight Loss in Male Obese Patients.Sun Jia · completed · Obesity · principal investigator
- Ph2NCT04535024 · The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal CancerFudan University · unknown · Colorectal Cancer · principal investigator
- Ph2NCT04499586 · A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal CancerFudan University · unknown · Recurrent Colorectal Cancer · principal investigator
- Ph2NCT04394598 · A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal CancerFudan University · unknown · Locally Advanced Rectal Cancer · principal investigator
- Ph2NCT03823079 · Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With ThrombocytopeniaFudan University · unknown · Recurrent Colorectal Carcinoma, Thrombopenia · study chair
- Ph2NCT03702985 · Radiation-protection Effect of Amifostine in Locally Advanced Rectal CancerFudan University · unknown · Locally Advanced Rectal Cancer · principal investigator
- N/ANCT03577808 · Organoids in Predicting Chemoradiation Sensitivity on Rectal CancerZhen Zhang · unknown · Organoids, Rectal Cancer, Chemoradiation · principal investigator
- Ph3NCT02605265 · Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1Fudan University · completed · Locally Advanced Rectal Cancer · principal investigator
- Ph2NCT02024217 · Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric CarcinomaFudan University · unknown · Gastric Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.